Cart
sales@molnova.com
MD2-TLR4-IN-1
CAS No. 2249801-12-3
MD2-TLR4-IN-1( —— )
Catalog No. M20941 CAS No. 2249801-12-3
MD2-TLR4-IN-1 is a myeloid differentiation protein 2/toll-like receptor 4 (MD2-TLR4) complex inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 144 | In Stock |
|
| 5MG | 130 | In Stock |
|
| 10MG | 212 | In Stock |
|
| 25MG | 363 | In Stock |
|
| 50MG | 498 | In Stock |
|
| 100MG | 658 | In Stock |
|
| 200MG | 886 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMD2-TLR4-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionMD2-TLR4-IN-1 is a myeloid differentiation protein 2/toll-like receptor 4 (MD2-TLR4) complex inhibitor.
-
DescriptionMD2-TLR4-IN-1 is a myeloid differentiation protein 2/toll-like receptor 4 (MD2-TLR4) complex inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorMD2-TLR4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2249801-12-3
-
Formula Weight421.28
-
Molecular FormulaC22H14Cl2N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 83.33 mg/mL (197.80 mM)
-
SMILESO=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhiguo Liu Lingfeng et al. Discovery of 3-(Indol-5-yl)-indazole Derivatives as Novel Myeloid Differentiation Protein 2/Toll-like Receptor 4 Antagonists for Treatment of Acute Lung Injury.[J]. Journal of medicinal chemistry 2019.
molnova catalog
related products
-
Enpatoran
Enpatoran is an inhibitor of TLR7(IC50 = 11.1 nM) and TLR8(IC50 = 24.1 nM). Enpatoran was found to be inactive against TLR3, TLR4, and TLR9 in vitro and in vivo.
-
Imiquimod 2HCl
Imiquimod 2HCl is a toll-like receptor 7 (TLR7) agonist and an immunomodulator with antiviral and antitumor activity.
-
CPG-52364
CPG-52364 (CPG52364) is an orally available, small molecule TLR7/8/9 antagonist for the treatment of systemic lupus erythematosus and other autoimmune disorders.
